Literature DB >> 26963903

Topical immunotherapy with diphenylcyclopropenone-induced vitiligo.

Zekayi Kutlubay1, Burhan Engin1, Abdullah Songur1, Server Serdaroglu1, Yalcin Tuzun1.   

Abstract

Topical immunotherapy made by diphenylcyclopropenone (DPCP) is an alternative treatment that can be used safely and efficaciously in recalcitrant alopecia areata patients. DPCP-induced vitiligo is a rare, but documented, unwanted side effect. The real mechanism of DPCP-induced vitiligo is not well known.

Entities:  

Keywords:  Diphenylcyclopropenone; topical immunotherapy; vitiligo

Mesh:

Substances:

Year:  2016        PMID: 26963903     DOI: 10.3109/14764172.2016.1157357

Source DB:  PubMed          Journal:  J Cosmet Laser Ther        ISSN: 1476-4172            Impact factor:   2.247


  2 in total

1.  Alopecia Areata as a Manifestation of Systemic Lymphoma: Report of Two Cases.

Authors:  Yuval Ramot; Alexander Gural; Abraham Zlotogorski
Journal:  Skin Appendage Disord       Date:  2016-08-04

Review 2.  Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.

Authors:  Kun-Wei Lai; Tsen-Fang Tsai
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.